not tagged
not tagged
['improve ', 'increase,(-increased)', 'sarcoma']
#esmo22 new data in osteosarcoma. more is not better. adding ifosphamide to map regimen in none responders osteosarcoma after neoadjuvant map do not improve survival and increase toxicity. 